SEC Form 13F

Bleichroeder LP 13F Holdings

Inspect Bleichroeder LP's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-14T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-14
Reported value
$558,937,707
Positions
78

Read this manager's filing book

Step 1 of 3

Disclosed positions

Bleichroeder LP: source evidence dated 2026-08-14T03:59:59.999Z.

Issuer
SPDR GOLD TR
Ticker
GLD
Class
GOLD SHS
Reported value
$174,980,500
Reported amount
475,000
Unit
SH
Option
None
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

What was reported for this quarter?

13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.

SEC 13F-HR: 0001420506-26-001619
What you should see

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Step 3 of 3

Browse institutional filings

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Browse institutional filings
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Disclosed positions

See the complete disclosed positions

Scroll sideways to compare all columns. Select a heading to sort.

SPDR GOLD TRGLDGOLD SHS$174,980,500475,000SHNone
GPGI INCGPGICOM CL A$62,958,9853,972,176SHNone
STATE STR SPDR S&P 500 ETF TSPYTR UNIT$50,515,25767,645SHNone
RESOLUTE HLDGS MGMT INCRHLDCOM$45,406,412314,166SHNone
LINDE PLCLINSHS$31,361,62060,434SHNone
DUOS TECHNOLOGIES GROUP INCDUOTCOM$19,533,6721,627,806SHNone
PRECISION BIOSCIENCES INCDTILCOM NEW$15,862,9732,018,190SHNone
CUE BIOPHARMA INCCUECOM$11,698,724370,682SHNone
BLACKSTONE INCBXCOM$10,678,55390,750SHNone
IMMIX BIOPHARMA INCIMMXCOM$10,310,0001,000,000SHNone
INTELLICHECK MOBILISA INCIDNCOM NEW$8,431,0062,056,343SHNone
S&P GLOBAL INCSPGICOM$8,145,20020,000SHNone
IDENTIV INCINVECOM NEW$7,268,9272,884,495SHNone
LIQTECH INTL INCLIQTCOM$5,843,0216,882,239SHNone
KAZIA THERAPEUTICS LTDKZIASPONSORED ADS$5,632,000400,000SHNone
ENVOY MEDICAL INCCOCHCL A$4,950,0006,250,000SHNone
CULLINAN THERAPEUTICS INCCGEMCOM$4,552,500250,000SHNone
WELLTOWER INCWELLCOM$4,539,40020,000SHNone
EYEPOINT INCEYPTCOM NEW$4,526,165316,515SHNone
FLUENT INCFLNTCOM NEW$4,262,8571,142,857SHNone
GENELUX CORPORATIONGNLXCOM$4,155,8051,380,666SHNone
PROKIDNEY CORPPROKSHS CL A$4,080,0002,000,000SHNone
COGENT BIOSCIENCES INCCOGTCOM$3,870,000100,000SHNone
INVESCO QQQ TRQQQUNIT SER 1$3,416,8964,640SHNone
JPMORGAN CHASE & COJPMCOM$3,338,76610,200SHNone
MDXHEALTH SAMDXHSHS NEW$3,029,5447,378,333SHNone
OPUS GENETICS INCIRDCOM$3,028,421736,842SHNone
GRUPO TELEVISA S A BTVSPON ADR REP ORD$2,791,3001,030,000SHNone
BARFRESH FOOD GROUP INCBRFHCOM NEW$2,781,5161,390,758SHNone
DIAMEDICA THERAPEUTICS INCDMACCOM NEW$2,691,512382,317SHNone
RANK ONE COMPUTING CORPROCCOM SHS$2,635,000500,000SHNone
SPIRE GLOBAL INCSPIRCOM CL A NEW$2,511,000135,000SHNone
IDEAL PWR INCIPWRCOM NEW$2,144,000400,000SHNone
NEUROONE MED TECHNOLOGIES CONMTCCOM$2,026,665666,666SHNone
CURIS INCCRISCOM$1,985,1963,802,329SHNone
REVOLUTION MEDICINES INCRVMDW*W EXP 12/17/202$1,875,980200,000SHNone
PROFOUND MED CORPPROFCOM NEW$1,694,107254,753SHNone
RENOVORX INCRNXTCOM NEW$1,632,7761,666,098SHNone
MODULAR MED INCMODDCOM NEW$1,516,437336,986SHNone
VENU HLDG CORPVENUCOM$1,362,000600,000SHNone
TALPHERA INCTLPHCOM NEW$1,347,0211,307,787SHNone
QT IMAGING HLDGS INCQTICOM$1,288,835316,667SHNone
LIBERTY LIVE HOLDINGS INCLLYVKCOM SHS SER C$1,174,82713,802SHNone
LIBERTY DEFENSE HLDGS LTDDETXCOM NEW$1,119,441277,777SHNone
REIN THERAPEUTICS INCRNTXCOM NEW$1,040,0001,000,000SHNone
OWLET INCOWLTCL A NEW$987,280172,000SHNone
SINTX TECHNOLOGIES INCSINTCOM NEW$978,034523,013SHNone
CELLECTAR BIOSCIENCES INCCLRBCOM NEW$802,528288,679SHNone
MAIA BIOTECHNOLOGY INCMAIACOM$720,000500,000SHNone
5E ADVANCED MATERIALS INCFEAMCOM NEW$637,696458,774SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 3 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.